Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Israelson

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Molecular Sciences|August 26, 2022
4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS MiceLeenor Alfahel, Shirel Argueti-Ostrovsky, Shir Barel, et al.
Scientific Reports|November 27, 2020
Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALSMarcel F Leyton-Jaimes, Patrik Ivert, Jan Hoeber, et al.
Biological Chemistry|August 9, 2023
Intracellular spatially-targeted chemical chaperones increase native state stability of mutant SOD1 barrelSara S Ribeiro, David Gnutt, Salome Azoulay-Ginsburg, et al.
Frontiers in Cellular Neuroscience|September 3, 2019
A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALSAnna Shteinfer-Kuzmine, Shirel Argueti, Rajeev Gupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein importQuan Li, Christine Vande Velde, Adrian Israelson, et al.
Chemmedchem|March 17, 2015
A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS)Tamar Getter, Ilana Zaks, Yael Barhum, et al.
Neuron|March 25, 2015
Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1Adrian Israelson, Dara Ditsworth, Shuying Sun, et al.
Cell Reports. Medicine|May 4, 2024
Targeting low levels of MIF expression as a potential therapeutic strategy for ALSLeenor Alfahel, Thomas Gschwendtberger, Velina Kozareva, et al.
Nature Neuroscience|October 3, 2025
Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS modelsAriel Ionescu, Lior Ankol, Anand Ganapathy Subramaniam, et al.
Nature|July 23, 2019
Potential roles of gut microbiome and metabolites in modulating ALS in miceEran Blacher, Stavros Bashiardes, Hagit Shapiro, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Molecular Sciences|August 26, 2022
4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS MiceLeenor Alfahel, Shirel Argueti-Ostrovsky, Shir Barel, et al.
Scientific Reports|November 27, 2020
Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALSMarcel F Leyton-Jaimes, Patrik Ivert, Jan Hoeber, et al.
Biological Chemistry|August 9, 2023
Intracellular spatially-targeted chemical chaperones increase native state stability of mutant SOD1 barrelSara S Ribeiro, David Gnutt, Salome Azoulay-Ginsburg, et al.
Frontiers in Cellular Neuroscience|September 3, 2019
A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALSAnna Shteinfer-Kuzmine, Shirel Argueti, Rajeev Gupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein importQuan Li, Christine Vande Velde, Adrian Israelson, et al.
Chemmedchem|March 17, 2015
A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS)Tamar Getter, Ilana Zaks, Yael Barhum, et al.
Neuron|March 25, 2015
Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1Adrian Israelson, Dara Ditsworth, Shuying Sun, et al.
Cell Reports. Medicine|May 4, 2024
Targeting low levels of MIF expression as a potential therapeutic strategy for ALSLeenor Alfahel, Thomas Gschwendtberger, Velina Kozareva, et al.
Nature Neuroscience|October 3, 2025
Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS modelsAriel Ionescu, Lior Ankol, Anand Ganapathy Subramaniam, et al.
Nature|July 23, 2019
Potential roles of gut microbiome and metabolites in modulating ALS in miceEran Blacher, Stavros Bashiardes, Hagit Shapiro, et al.
Pageof 4